Teladoc Health Reports Third Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Teladoc (TDOC) Tops Q3 EPS by 12c, Revenues Beat; Updates FY19 EPS/Revenue Guidance Above Consensus, Affirms Q4 EPS/Revenue Views
October 30, 2019 5:07 PM EDTTeladoc (NYSE: TDOC) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $138 million versus the consensus estimate of $136.47 million.
Year-over-year Q3 revenue grows 24% to $138.0 million and total visits increase 45% to 928,000Year-over-year nine months revenue grows 34% to $396.8 million and total visits increase 63% to 2,899,000Issues 2019 fourth-quarter guidance and updates full-year expectationsThe third quarter marked a continuation of Teladoc Healths very strong momentum from the first half of the year, as we... More
